← Leaderboards
Pai-Lien Chen
University Of Cape Town
$814,567
Attributed
$1,629,134
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $653.5K · FY2022–24$1M$750K$500K$250K$0
'22
'23
'24
Funding mix
By agency
NIH$1,629,134 · 1
By mechanism
R01$1,629,134 · 1
Top collaborators
- Janet Patricia Hapgood3 shared
Most similar at University Of Cape Town
Same institution · by research overlap
- Linda-Gail Bekker$40,471,276
- Robert John Wilkinson$5,301,802
- Janet Patricia Hapgood$2,405,360
- Sean Adam Wasserman$2,761,994
- Mpiko Ntsekhe$1,390,313
Others in their field
Other Rising Stars on “Women&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Karen L Florio · University Of Missouri Kansas City$2,288,976
- Abbi Danielle Lane · University Of Michigan At Ann Arbor$2,125,559
- Jeremy Joseph Pruzin · Utah State Higher Education System--University Of Utah$1,929,922
- Sanika Samuel Chirwa · Meharry Medical College$1,756,675
- Tatyana Kushner · Icahn School Of Medicine At Mount Sinai$1,387,120
Research focus
Women&AposAgedBiologicalAndrogensAreaBehavioralAndrogenicBiological MarkersBiometryBlack WomenBlood SpecimenCcr5 GeneCell ModelCellsAfrica South Of The SaharaClinical DataClinical PracticeClinical TrialsContraceptive AgentsContraceptive EfficacyContraceptive MethodsDisadvantagedDiscriminationAffect
Grant awards (3)
Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate.$653,530
R01 · FY2024 · AI
Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate.$629,850
R01 · FY2023 · AI
Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate.$345,754
R01 · FY2022 · AI